Patients
Pregnant women aged over 18 years in the second or third trimester with
ID, defined as ferritin ≤ 15 μg/l and a transferrin saturation
< 25% were eligible. Participants were excluded if they had
untreated B12 or folate deficiencies, known hypersensitivity to FCM,
haemoglobin >130 g.l-1; serious medical
condition, uncontrolled systemic disease, or inability to fully
comprehend or perform study procedures. Women were screened for ID
during routine antenatal assessment at the Women’s Assessment Unit at
the Lyell McEwin Hospital, Elisabeth Vale, South Australia.